Oyama S, Kinoshita K, Ninomiya I, Yonemura Y, Miyazaki I, Tanaka M, Sasaki T
Department of Surgery II, School of Medicine, Kanazawa University, Japan.
Nihon Geka Gakkai Zasshi. 1991 Oct;92(10):1444-50.
The usefulness of an in vitro human tumor culture system using a specialized collagen gel matrix derived from pig skin was retrospectively evaluated as a chemosensitivity test for human gastric carcinomas. Seven xenograft tumors derived from human gastric cancers were examined by this system (CGM assay) and compared with the data obtained by a nude mice assay (NM assay) and a succinic dehydrogenase inhibition test (SDI test). Xenograft tumors had three-dimensional growth on the collagen gel matrix like that in vivo. There was increasing cell kill with rising cytotoxic drug concentration. When drug sensitivity was evaluated as effective based on an inhibition rate of 40% or more in the CGM assay, drug sensitivity as measured by the CGM assay corresponded with that measured by the NM assay for all xenograft tumors but not the SDI test. This system could be applied for chemosensitivity test of scirrhous gastric carcinomas. It was suggested that the CGM assay may be more like an in vivo like chemosensitivity test and clinically useful testing for the patients with gastric cancer, including scirrhous one.
使用源自猪皮的特殊胶原凝胶基质的体外人肿瘤培养系统作为人胃癌的化学敏感性试验进行了回顾性评估。通过该系统(CGM 试验)检查了 7 个源自人胃癌的异种移植肿瘤,并与通过裸鼠试验(NM 试验)和琥珀酸脱氢酶抑制试验(SDI 试验)获得的数据进行了比较。异种移植肿瘤在胶原凝胶基质上呈三维生长,类似于体内生长情况。随着细胞毒性药物浓度的升高,细胞杀伤作用增强。当在 CGM 试验中基于 40%或更高的抑制率将药物敏感性评估为有效时,CGM 试验测得的药物敏感性与 NM 试验对所有异种移植肿瘤测得的药物敏感性相符,但与 SDI 试验不符。该系统可用于硬癌性胃癌的化学敏感性试验。有人提出,CGM 试验可能更类似于体内化学敏感性试验,对包括硬癌性胃癌患者在内的胃癌患者具有临床有用性。